CBLL

Ceribell, Inc.

Nasdaq · Electromedical & Electrotherapeutic Apparatus · Inc. DE · CIK 0001861107
$18.47 +1.76% $700.8M
Insider Selling Cluster (5 insiders)High Impact Filing (8/10)7 New Institutional Positions
Vol
Market Cap$700.8M
Cap SizeSmall Cap
Analyst ConsensusStrong Buy (93%)
Inst. Holders50 funds
Inst. Value$280.7M
Inst. Activity7 buys / 2 sells
Insider Activity0B / 22S
Insider Net $-$2.1M
SEC Reports13
Exchange Nasdaq·Sector Electromedical & Electrotherapeutic Apparatus·Inc. DE·CIK 0001861107·Prev Close $18.15

Recent Activity

Jun 8, 2026 other
Ceribell Announces New Critical Care Medicine Publication Reinforcing Link Between Seizure Burden Measured by Clarity AI Algorithm and Neurological Outcomes
Study published in leading critical care journal shows that higher AI-detected seizure burden is ass
Jun 8, 2026 Insider
Chao Xingjuan sold 14,000 shares
President and CEO @ $18.33 ($256.6K)
Jun 8, 2026 Insider
Chao Xingjuan acquired via exercise 1,446 shares
President and CEO @ $4.70 ($6.8K)
Jun 2, 2026 Insider
Tammenoms Bakker Juliet was granted 7,838 shares
Director
May 26, 2026 SEC
Five Ceribell insiders, including the CEO, CFO, CTO, and CRO, sold a total of $211K in open-market shares over a one-wee
CLUSTER — Impact 2/10
May 11, 2026 SEC
Ceribell reported Q1 2026 revenue of $26.5M (+29% YoY), beating the $26.1M consensus, and EPS of -$0.52 (GAAP) vs consen
PRESS-RELEASE — Impact 6/10
May 7, 2026 SEC
Insider cluster at Ceribill showing two sells by CEO and CTO totaling ~$312K, which is only 0.04% of market cap. Derivat
CLUSTER — Impact 2/10
Inst.
FRANKLIN RESOURCES INC — ADD
809,514 shares ($14.8M)

Price Targets

$26.86 +45.4% upside Strong Buy
Current $18.47 Low $24.00 Median $26.00 High $32.00 7 analysts
$24.00 $32.00

Analyst Ratings

Strong Buy93% buy · 14 analysts
7Strong Buy
6Buy
1Hold
0Sell
0Strong Sell
Recent Analyst Actions
DateFirmActionRating
May 12, 2026 Canaccord Genuity MAINTAIN Buy → Buy
Jan 28, 2026 BTIG REITERATE Buy → Buy
Dec 17, 2025 Canaccord Genuity MAINTAIN Buy → Buy

Earnings Estimates

PeriodEPS Est.RangeGrowth#
Current Q $-0.46 ▼ -17.6% $-0.50 — $-0.36 -21% YoY 4
Next Q $-0.37 ▼ -5.6% $-0.38 — $-0.34 -0% YoY 4
Current FY $-1.68 ▼ -15.5% $-1.74 — $-1.55 -15% YoY 4
Next FY $-1.10 ▼ -9.2% $-1.30 — $-0.91 35% YoY 5

Latest Reports

NEUTRAL CLUSTER 2/10
Five Ceribell insiders, including the CEO, CFO, CTO, and CRO, sold a total of $211K in open-market shares over a one-wee
May 26, 2026
MIXED PRESS-RELEASE 6/10
Ceribell reported Q1 2026 revenue of $26.5M (+29% YoY), beating the $26.1M consensus, and EPS of -$0.52 (GAAP) vs consen
May 11, 2026

Top Institutional Holders

FundValueMove
FMR LLC$88.9M—
BlackRock, Inc.$33.2M—
VANGUARD CAPITAL MANAGEMENT LLC$20.8M—
FEDERATED HERMES, INC.$17.2MDOUBLED
FRANKLIN RESOURCES INC$14.8MADD

Recent Insider Trades

DateInsiderTypeValue
Jun 8, 2026Chao XingjuanSELL$256.6K
Jun 8, 2026Chao XingjuanM$6.8K
Jun 2, 2026Tammenoms BakkerA$0.00
Jun 2, 2026ROBERTSON REBECCAA$0.00
Jun 2, 2026Taylor JosephA$0.00
50 institutional holders with $280.7M total value (15,452,578 shares) as of 2026-Q1. Top holders: FMR, BlackRock,, VANGUARD. Net buying activity: 7 institutions added/increased vs 2 reduced.

Top Institutional Holders — 2026-Q1

#FundSharesValue% of TrackedLast Move
1FMR LLC4,850,431$88.9M31.7%—
2BlackRock, Inc.1,813,155$33.2M11.8%—
3VANGUARD CAPITAL MANAGEMENT LLC1,137,132$20.8M7.4%—
4FEDERATED HERMES, INC.939,464$17.2M6.1%DOUBLED +111.3%
5FRANKLIN RESOURCES INC809,514$14.8M5.3%ADD +54.7%
6ADAGE CAPITAL PARTNERS GP, L.L.C.756,751$13.9M4.9%ADD +51.4%
7STATE STREET CORP525,432$9.6M3.4%ADD +76.0%
8ROYCE & ASSOCIATES LP515,720$9.5M3.4%NEW
9MASSACHUSETTS FINANCIAL SERVICES CO /MA/508,490$9.3M3.3%ADD +33.2%
10SILVERCREST ASSET MANAGEMENT GROUP LLC489,742$9.0M3.2%ADD +50.7%
11GOLDMAN SACHS GROUP INC411,031$7.5M2.7%—
12TWO SIGMA INVESTMENTS, LP326,032$6.0M2.1%ADD +81.0%
13BANK OF AMERICA CORP /DE/319,837$5.9M2.1%DOUBLED +104.4%
14CITADEL ADVISORS LLC288,114$5.3M1.9%—
15MORGAN STANLEY230,918$4.2M1.5%ADD +35.7%
16VANGUARD PORTFOLIO MANAGEMENT LLC214,201$3.9M1.4%—
17CHARLES SCHWAB INVESTMENT MANAGEMENT INC189,482$3.5M1.2%ADD +26.6%
18VANGUARD FIDUCIARY TRUST CO163,066$3.0M1.1%—
19DEUTSCHE BANK AG\88,502$1.6M0.6%—
20D. E. Shaw & Co., Inc.84,721$1.6M0.6%—

Recent Position Changes

FundActionPrev SharesCurr SharesChange %ValueQuarter
FRANKLIN RESOURCES INCADD523,354809,514+54.7%$14.8M2026-Q1
ADAGE CAPITAL PARTNERS GP, L.L.C.ADD500,000756,751+51.4%$13.9M2026-Q1
Verition Fund Management LLCADD11,89222,716+91.0%$416.4K2026-Q1
Invesco Ltd.ADD12,03718,511+53.8%$339.3K2026-Q1
CWM, LLCDOUBLED1,8414,526+145.8%$83.0K2026-Q1
Allworth Financial LPADD319413+29.5%$7.6K2026-Q1
NISA INVESTMENT ADVISORS, LLCTRIM402272-32.3%$5.0K2026-Q1
HRT FINANCIAL LPTRIM255,584135,423-47.0%$2.5K2026-Q1
PNC FINANCIAL SERVICES GROUP, INC.DOUBLED514+180.0%$257.002026-Q1
SILVERCREST ASSET MANAGEMENT GROUP LLCADD359,876542,276+50.7%$11.9M2025-Q4
ROYCE & ASSOCIATES LPNEW—533,300—$11.7M2025-Q4
ADAGE CAPITAL PARTNERS GP, L.L.C.NEW—500,000—$11.0M2025-Q4
BANK OF AMERICA CORP /DE/DOUBLED135,783277,497+104.4%$6.1M2025-Q4
MORGAN STANLEYADD154,545209,668+35.7%$4.6M2025-Q4
ALLIANCEBERNSTEIN L.P.ADD42,32467,334+59.1%$1.5M2025-Q4
WELLS FARGO & COMPANY/MNADD15,50629,355+89.3%$643.8K2025-Q4
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.TRIM21,15312,369-41.5%$271.3K2025-Q4
Russell Investments Group, Ltd.ADD2,0642,918+41.4%$64.0K2025-Q4
Legal & General Group PlcTRIM7,5652,817-62.8%$61.8K2025-Q4
CWM, LLCDOUBLED1441,841+1178.5%$40.002025-Q4
TWO SIGMA INVESTMENTS, LPADD164,639297,963+81.0%$3.4M2025-Q3
UBS Group AGADD149,437256,919+71.9%$3.0M2025-Q3
CHARLES SCHWAB INVESTMENT MANAGEMENT INCADD128,048162,167+26.6%$1.9M2025-Q3
BANK OF AMERICA CORP /DE/ADD72,568135,783+87.1%$1.6M2025-Q3
Nuveen, LLCTRIM91,63354,563-40.5%$626.9K2025-Q3
11 unique insiders with 50 transactions. Net insider value: -$2.1M ($0.00 bought, $2.1M sold).

Insider Transactions

DateInsiderTitleTypeSharesPriceValue
Jun 8, 2026Chao XingjuanPresident and CEOSELL14,000$18.33$256.6K
Jun 8, 2026Chao XingjuanPresident and CEOEXERCISE1,446$4.70$6.8K
Jun 2, 2026Tammenoms Bakker JulietDirectorAWARD7,838——
Jun 2, 2026ROBERTSON REBECCA BDirectorAWARD7,838——
Jun 2, 2026Taylor Joseph MichaelDirectorAWARD7,838——
Jun 2, 2026BURKE WILLIAM WDirectorAWARD7,838——
Jun 2, 2026Rogers Erica J.DirectorAWARD7,838——
Jun 2, 2026Parvizi JosefDirectorAWARD7,838——
May 22, 2026Foehr DavidSenior VP, Finance and PAOSELL862$18.80$16.2K
May 21, 2026Chao XingjuanPresident and CEOSELL6,030$18.00$108.5K
May 21, 2026Woo RaymondChief Technology OfficerSELL1,966$18.00$35.4K
May 21, 2026Blumberg ScottChief Financial OfficerSELL1,387$18.00$25.0K
May 21, 2026Foehr DavidSenior VP, Finance and PAOSELL987$18.00$17.8K
May 21, 2026Manni Joseph S.Chief Revenue OfficerSELL1,378$18.00$24.8K
May 5, 2026Chao XingjuanPresident and CEOEXERCISE1,446$4.70$6.8K
May 5, 2026Chao XingjuanPresident and CEOSELL14,000$20.12$281.7K
May 1, 2026Woo RaymondChief Technology OfficerEXERCISE1,469$2.24$3.3K
May 1, 2026Woo RaymondChief Technology OfficerSELL1,469$20.39$30.0K
Apr 6, 2026Chao XingjuanPresident and CEOEXERCISE1,446$4.70$6.8K
Apr 6, 2026Chao XingjuanPresident and CEOSELL14,000$18.40$257.6K
Apr 1, 2026Manni Joseph S.Chief Revenue OfficerAWARD51,227——
Apr 1, 2026Manni Joseph S.Chief Revenue OfficerAWARD30,736——
Apr 1, 2026Chao XingjuanPresident and CEOAWARD162,592——
Apr 1, 2026Chao XingjuanPresident and CEOAWARD97,555——
Apr 1, 2026Blumberg ScottChief Financial OfficerAWARD51,227——
Apr 1, 2026Blumberg ScottChief Financial OfficerAWARD30,736——
Apr 1, 2026Woo RaymondChief Technology OfficerAWARD51,227——
Apr 1, 2026Foehr DavidSenior VP, Finance and PAOAWARD36,750——
Apr 1, 2026Woo RaymondChief Technology OfficerAWARD30,736——
Apr 1, 2026Woo RaymondChief Technology OfficerSELL1,472$18.58$27.3K
Apr 1, 2026Woo RaymondChief Technology OfficerEXERCISE1,472$2.24$3.3K
Apr 1, 2026Foehr DavidSenior VP, Finance and PAOAWARD22,050——
Mar 25, 2026Chao XingjuanPresident and CEOEXERCISE36,628$2.24$82.0K
Mar 10, 2026Manni Joseph S.Chief Revenue OfficerAWARD3,500——
Mar 3, 2026ROBERTSON REBECCA BDirectorSELL827$17.80$14.7K
Mar 3, 2026Foehr DavidSenior VP, Finance and PAOEXERCISE3,403$4.70$16.0K
Mar 3, 2026Chao XingjuanPresident and CEOSELL14,000$17.45$244.3K
Mar 3, 2026Chao XingjuanPresident and CEOEXERCISE1,446——
Mar 2, 2026Woo RaymondChief Technology OfficerEXERCISE1,472$2.24$3.3K
Feb 24, 2026Foehr DavidSenior VP, Finance and PAOSELL781$19.98$15.6K
Feb 23, 2026Foehr DavidSenior VP, Finance and PAOSELL569$19.79$11.3K
Feb 23, 2026Blumberg ScottChief Financial OfficerSELL808$19.79$16.0K
Feb 23, 2026Chao XingjuanPresident and CEOSELL2,084$19.79$41.2K
Feb 23, 2026Manni Joseph S.Chief Revenue OfficerSELL768$19.79$15.2K
Feb 23, 2026Woo RaymondChief Technology OfficerSELL705$19.79$14.0K
Feb 19, 2026Parvizi JosefDirectorSELL16,714$20.27$338.8K
Feb 4, 2026Chao XingjuanPresident and CEOSELL14,000$20.16$282.2K
Feb 4, 2026Chao XingjuanPresident and CEOEXERCISE1,446$4.70$6.8K
Feb 3, 2026Foehr DavidSenior VP, Finance and PAOSELL3,403$20.00$68.1K
Feb 3, 2026Foehr DavidSenior VP, Finance and PAOEXERCISE3,403$4.70$16.0K
13 SEC filing reports analyzed. Sentiment: 1 bullish, 4 bearish, 1 mixed, 7 neutral. Avg impact: 4.4/10.
NEUTRAL CLUSTER 2/10
Five Ceribell insiders, including the CEO, CFO, CTO, and CRO, sold a total of $211K in open-market s
May 26, 2026
MIXED PRESS-RELEASE 6/10
Ceribell reported Q1 2026 revenue of $26.5M (+29% YoY), beating the $26.1M consensus, and EPS of -$0
May 11, 2026
NEUTRAL CLUSTER 2/10
Insider cluster at Ceribill showing two sells by CEO and CTO totaling ~$312K, which is only 0.04% of
May 7, 2026
NEUTRAL PRESS-RELEASE 3/10
Ceribell issued a press release announcing the upcoming release of its Q1 2026 financial results, wi
Apr 20, 2026
NEUTRAL DEFA14A 3/10
Ceribell, Inc. filed a definitive proxy statement (DEFA14A) for its upcoming shareholder meeting. Th
Apr 20, 2026
BEARISH CLUSTER 5/10
Ceribell CEO Chao Xingjuan and CTO Woo Raymond sold a combined $285K in shares over the past week, w
Apr 8, 2026
NEUTRAL CLUSTER 3/10
Ceribell's CEO and CTO sold shares within the past week, with CEO Chao Xingjuan selling $244,300 wor
Mar 5, 2026
NEUTRAL CLUSTER 2/10
Ceribell's Chief Technology Officer, Raymond Woo, exercised stock options for 1,472 shares at $2.24
Mar 4, 2026
NEUTRAL INST-CLUSTER 5/10
Three major passive institutional investors — Morgan Stanley, Wells Fargo, and Schwab — initiated ne
Feb 28, 2026
BEARISH CLUSTER 6/10
Six Ceribell executives, including the CEO, CFO, CTO, and other C-suite leaders, sold shares in a co
Feb 26, 2026
BEARISH CLUSTER 6/10
Six Ceribell executives sold shares in a concentrated 7-day window, including CEO Chao Xingjuan and
Feb 25, 2026
BEARISH CLUSTER 6/10
Six corporate insiders at Ceribell, Inc. (CBLL) sold shares in a concentrated 7-day window, includin
Feb 25, 2026
BULLISH 8-K, 8-K 8/10
Ceribell reported strong financial results for Q4 and full year 2025, with revenue growth of 34% and
Feb 24, 2026
∅

No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.

Current analyst consensus: Strong Buy (93% buy). Based on 14 analysts: 7 strong buy, 6 buy, 1 hold, 0 sell, 0 strong sell.

Analyst Price Targets

$26.86 mean target +45.4% upside Strong Buy (1.13)
$24.00 Low $32.00 High
MetricValue
Current Price$18.47
Target Low$24.00
Target Mean$26.86
Target Median$26.00
Target High$32.00
# Analysts7
RecommendationStrong Buy (1.13)

Earnings Estimates & Revisions

PeriodEPS AvgEPS LowEPS HighEPS Growth30d Rev.Up/DownRev. AvgRev. GrowthAnalysts
Current Q
2026-06-30
 $-0.46 $-0.50 $-0.36 -20.6% -17.6% 0↑ 3↓ $0.0B 28.7% 4
Next Q
2026-09-30
 $-0.37 $-0.38 $-0.34 -0.1% -5.6% 1↑ 2↓ $0.0B 27.7% 4
Current FY
2026-12-31
 $-1.68 $-1.74 $-1.55 -15.2% -15.5% 0↑ 3↓ $0.1B 28.0% 4
Next FY
2027-12-31
 $-1.10 $-1.30 $-0.91 34.7% -9.2% 1↑ 3↓ $0.1B 28.0% 5

Current Quarter EPS Revision History

TimepointEPS EstimateChange
Current$-0.458
7d ago$-0.390-0.069
30d ago$-0.390-0.069
60d ago$-0.390-0.069
90d ago$-0.368-0.090
2 analyst firms have rated this stock: 0 upgrades, 0 downgrades, 0 initiations.

Individual Analyst Actions

DateAnalyst FirmActionPrevious RatingNew Rating
May 12, 2026 Canaccord Genuity MAINTAIN Buy Buy
Jan 28, 2026 BTIG REITERATE Buy Buy
Dec 17, 2025 Canaccord Genuity MAINTAIN Buy Buy

Monthly Consensus History

PeriodStrong BuyBuyHoldSellStrong SellBuy %Distribution
Jun 1, 20267610093%
May 1, 20267610093%
Apr 1, 20267610093%
Mar 1, 20267610093%
Feb 1, 20267610093%
Jan 1, 20267610093%
Strong BuyBuyHoldSellStrong Sell
∅

No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.

∅

No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.

Jun 8, 2026
other
Ceribell Announces New Critical Care Medicine Publication Reinforcing Link Between Seizure Burden Measured by Clarity AI Algorithm and Neurological Outcomes
Study published in leading critical care journal shows that higher AI-detected seizure burden is associated with increased odds of disability, further
May 20, 2026
other
Ceribell to Participate in the William Blair 46th Annual Growth Stock Conference
<p>SUNNYVALE, Calif., May 20, 2026 (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL) (“Ceribell”), a medical technology company focused on transform
May 11, 2026
earnings
Ceribell Reports First Quarter 2026 Financial Results
<p align="left">SUNNYVALE, Calif., May 11, 2026 (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL) (“Ceribell”), a medical technology company focused
May 11, 2026
earnings_calendar
CBLL Q1 2026 Earnings Scheduled — 2026-05-11
Apr 20, 2026
earnings
Ceribell to Report First Quarter 2026 Financial Results on May 11, 2026
<p>SUNNYVALE, Calif., April 20, 2026 (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL) (“Ceribell”), a medical technology company focused on transfo
Feb 24, 2026
earnings_calendar
CBLL Q4 2025 Earnings After Market Close — 2026-02-24